Del. Justices Allow Nixing Of Biopharma Officer Salary Suit
The Delaware Supreme Court upheld a trial court decision tossing an investor suit against Ultragenyx Pharmaceutical Inc. over allegedly excessive board salaries, agreeing Thursday that there were procedural flaws relating to...To view the full article, register now.
Already a subscriber? Click here to view full article